-
Meta-analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-18 Asif A. Hitawala, Harish Gopalakrishna, Maria Mironova, Alicia A. Livinski, Elizabeth C. Wright, Tacy Downing, Seiji Ito, Stacy D. Fisher, Ari M. Cedars, Anitha S. John, Theo Heller
-
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-18 Antonio De Vincentis, Federica Tavaglione, Shinichi Namba, Masahiro Kanai, Yukinori Okada, Yoichiro Kamatani, Samantha Maurotti, Claudio Pedone, Raffaele Antonelli Incalzi, Luca Valenti, Stefano Romeo, Umberto Vespasiani-Gentilucci
-
Towards unifying fatty liver nomenclature: a voice from the Middle East and North Africa Nat. Rev. Gastroenterol. Hepatol. (IF 65.1) Pub Date : 2024-03-18 Yasser Fouad, Salma Barakat, Almoutaz Hashim, Hasmik Ghazinyan
Fatty liver disease is one of the most common liver diseases in the Middle East and North Africa region, and globally. Unfortunately, there is a lack of awareness regarding this condition. The nomenclature changes for NAFLD (to MAFLD or MASLD) have gained considerable attention in the hepatology community. Here, we present our point of view on this ongoing change and debate.
-
Efficacy of the traction method in gastric endoscopic submucosal dissection: A randomized controlled trial Gastrointest. Endosc. (IF 7.7) Pub Date : 2024-03-18 Jun Kinoshita MD, Mikitaka Iguchi MD PhD, Takao Maekita MD PhD, Ke Wan PhD, Toshio Shimokawa PhD, Kazuhiro Fukatsu MD PhD, Shinya Taki MD, Fumiaki Kuwashima MD, Masaki Takao MD, Masayuki Kitano MD PhD
To overcome the technical difficulties associated with gastric ESD, a novel traction device that can alter the direction of traction was developed. Here, we compared the efficacy and safety of conventional ESD with that of traction-assisted gastric ESD. Patients with a single gastric epithelial neoplasm were randomized to receive conventional (n=75) or traction-assisted (n=73) gastric ESD. The primary
-
Response Gastrointest. Endosc. (IF 7.7) Pub Date : 2024-03-18 Fady F. Youssef MD MS, Samir Gupta MD MSCS, Gobind Anand MD
-
-
Response Gastrointest. Endosc. (IF 7.7) Pub Date : 2024-03-18 Zaheer Nabi MD DNB, D. Nageshwar Reddy MD DM
-
Oblique fiber preservation in the prevention of GERD after peroral endoscopic myotomy Gastrointest. Endosc. (IF 7.7) Pub Date : 2024-03-18 Yusuke Fujiyoshi MD, Robert Bechara MD, Christopher Teshima MD PhD
-
Harnessing all endoscopic techniques for the management of peptic ulcer bleeding Gastrointest. Endosc. (IF 7.7) Pub Date : 2024-03-18 Maria Manuela Estevinho MD, Teresa Freitas MD, Rolando Pinho MD
-
Different cancers in the same basket: intraductal papillary mucinous neoplasm-derived versus concomitant pancreatic carcinomas Gastrointest. Endosc. (IF 7.7) Pub Date : 2024-03-18 Hiroki Oyama MD PhD, Tsuyoshi Hamada MD MPH PhD, Yousuke Nakai MD PhD, Mitsuhiro Fujishiro MD PhD
-
Propensity score matching is needed to evaluate the clinical success rate of peroral endoscopic myotomy Gastrointest. Endosc. (IF 7.7) Pub Date : 2024-03-18 Yangyang Zhou MD, Qihang Guo MD, Shimeng Zheng MD, Deliang Li MD
-
Stent migration after Endoscopic Retrograde Appendicitis Therapy Gastrointest. Endosc. (IF 7.7) Pub Date : 2024-03-17 Qingfeng Wang MD, Zhongbo Han MD, Qiang Zhao MD, Weijuan Xu MD
-
BaiJ and BaiB are key enzymes in the chenodeoxycholic acid 7α-dehydroxylation pathway in the gut microbe Clostridium scindens ATCC 35704 Gut Microbes (IF 12.2) Pub Date : 2024-03-11 Karin Lederballe Meibom, Solenne Marion, Colin Volet, Théo Nass, Eduard Vico-Oton, Laure Menin, Rizlan Bernier-Latmani
Bile acid transformation is a common gut microbiome activity that produces secondary bile acids, some of which are important for human health. One such process, 7α-dehydroxylation, converts the pri...
-
Genetic evidence for repurposing of glucagon-like peptide-1 receptor agonists to prevent chronic liver diseases Gut (IF 24.5) Pub Date : 2024-03-15 Baike Liu, Ge Peng, Yuan Yin, Chaoyong Shen, Xiaonan Yin, Zhaolun Cai, Bo Zhang
We read with great interest the study of Wester et al 1 that suggested a potential hepatoprotective effect of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in mitigating the risk of major adverse liver outcomes among patients with type 2 diabetes (T2D). Currently, several studies indicate that GLP-1RAs provide functional protection for chronic liver diseases.2 3 However, uncertainties persist
-
Efficacy of Drugs Acting on Histamine-1 Receptors in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gastroenterology (IF 29.4) Pub Date : 2024-03-16 Mais Khasawneh, Christopher J. Black, Alexander C. Ford
-
Disparities in Gastric Cancer Screening: A Comparative Analysis of Japan and South Korea Gastroenterology (IF 29.4) Pub Date : 2024-03-16 Yasutoshi Shiratori MD. MPH. PhD., Naoki Ishii MD. MPH. PhD., Anthony Kalloo MD.
-
Machines advancing: marginalization of human beings on the horizon? Gastroenterology (IF 29.4) Pub Date : 2024-03-16 Emanuele Rondonotti, Franco Radaelli
-
Three-dimensional imaging of the enteric nervous system in human pediatric colon reveals new features of Hirschsprung disease Gastroenterology (IF 29.4) Pub Date : 2024-03-16 Joshua D. Eisenberg, Rebecca P. Bradley, Kahleb D. Graham, Rachel H. Ceron, Amanda M. Lemke, Benjamin J. Wilkins, Ali Naji, Robert O. Heuckeroth
Hirschsprung disease is defined by the absence of enteric nervous system (ENS) from distal bowel. Primary treatment is “pull-through” surgery to remove bowel that lacks ENS with re-anastomosis of “normal” bowel near the anal verge. Problems after pull-through are common and some may be due to retained hypoganglionic bowel (i.e., low ENS density). Testing this hypothesis has been difficult because counting
-
The snare-based pre-traction method facilitating endoscopic full-thickness resection of a bidirectional prominent dumbbell-shaped gastrointestinal stromal tumor in gastric fundus Gastrointest. Endosc. (IF 7.7) Pub Date : 2024-03-16 Fu-Qiang Liu MD, Xiang-Rong Zhou MD, Wen-Juan Ding MD, Zhi-Qiang Du MD, Wei-Hui Liu MD PhD
-
From palliative care to a definite cure: a severe presentation of Whipple Disease Gastrointest. Endosc. (IF 7.7) Pub Date : 2024-03-16 Margarida Rajão Saraiva, Daniel Conceição, Joana Lemos Garcia, Sara da Mata, João Pedro Caldeira, Pedro Currais, Carolina Simões
-
Stress in the microbiome-immune crosstalk Gut Microbes (IF 12.2) Pub Date : 2024-03-15 Eléonore Beurel
The gut microbiota exerts a mutualistic interaction with the host in a fragile ecosystem and the host intestinal, neural, and immune cells. Perturbations of the gastrointestinal track composition a...
-
Future direction of total neoadjuvant therapy for locally advanced rectal cancer Nat. Rev. Gastroenterol. Hepatol. (IF 65.1) Pub Date : 2024-03-14 Yoshinori Kagawa, J. Joshua Smith, Emmanouil Fokas, Jun Watanabe, Andrea Cercek, Florian R. Greten, Hideaki Bando, Qian Shi, Julio Garcia-Aguilar, Paul B. Romesser, Natally Horvat, Hanna Sanoff, William Hall, Takeshi Kato, Claus Rödel, Arvind Dasari, Takayuki Yoshino
-
Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study Gut (IF 24.5) Pub Date : 2024-03-14 Xue Xiao, Xian Zhang, Jin Wang, Yuqiang Liu, Hailin Yan, Xiaocun Xing, Jinlin Yang
Background The mechanism by which proton pump inhibitors (PPIs) alter gut microbiota remains to be elucidated. We aimed to learn whether PPI induced gut microbiota alterations by promoting oral microbial translocation. Methods Healthy adult volunteers were randomly assigned: PP group (n=8, 40 mg esomeprazole daily for seven days) and PM group (n=8, 40 mg esomeprazole along with chlorhexidine mouthwash
-
Comments on "Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022" Gastroenterology (IF 29.4) Pub Date : 2024-03-15 Jia Xu M.D., Mingming Deng M.D., Xiaowei Tang M.D. Ph.D.
-
Helicobacter pylori Therapy and Risk of Gastric Cancer After Endoscopic Resection of Dysplasia: A Sensitivity Analysis Assessing Impact of Unmeasured Confounding Gastroenterology (IF 29.4) Pub Date : 2024-03-15 Guo-Fu Li PhD, Yu-Wei Qiao BSc, Guo Yu PhD
-
Targeting ESE3/EHF with Nifurtimox inhibits CXCR2+ neutrophil infiltration and overcomes pancreatic cancer resistance to chemotherapy and immunotherapy Gastroenterology (IF 29.4) Pub Date : 2024-03-15 Yongjie Xie, Tianxing Zhou, Xueyang Li, Kaili Zhao, Weiwei Bai, Xupeng Hou, Ziyun Liu, Bo Ni, Zhaoyu Zhang, Jingrui Yan, Yifei Wang, Wenna Jiang, Hongwei Wang, Antao Chang, Song Gao, Tiansuo Zhao, Shengyu Yang, Chongbiao Huang, Jing Liu, Jihui Hao
Since pancreatic cancer responds poorly to chemotherapy and immunotherapy, it is necessary to identify novel targets and compounds to overcome resistance to treatment. This study analyzed genomic SNP sequencing, single-cell RNA sequencing, and spatial transcriptomics. knockout mice, KPC (LSL-Kras, LSL-Trp53 and Pdx1-Cre) mice, CD45.1+BALB/C nude mice, and CD34+humanized mice were also used as subjects
-
Amphiregulin switches progenitor cell fate for lineage commitment during gastric mucosal regeneration Gastroenterology (IF 29.4) Pub Date : 2024-03-15 Su-Hyung Lee, Yoonkyung Won, David Gibbs, Brianna Caldwell, Anna Goldstein, Eunyoung Choi, James R. Goldenring
Isthmic progenitors, tissue-specific stem cells in the stomach corpus, maintain mucosal homeostasis by balancing between proliferation and differentiation to gastric epithelial lineages. The progenitor cells rapidly adopt an active state in response to mucosal injury. However, it remains unclear how the isthmic progenitor cell niche is controlled during the regeneration of damaged epithelium. We recapitulated
-
A Hairy Pedunculated Polypoid Lesion of Sigmoid Colon in a Female with Abdominal Pain and Diarrhea Gastrointest. Endosc. (IF 7.7) Pub Date : 2024-03-15 Puo-Hsien Le MD, Yung-Kuan Tsou MD, Ren-Chin Wu MD PhD
-
Cell senescence in liver diseases: pathological mechanism and theranostic opportunity Nat. Rev. Gastroenterol. Hepatol. (IF 65.1) Pub Date : 2024-03-14 David Sanfeliu-Redondo, Albert Gibert-Ramos, Jordi Gracia-Sancho
-
ECCO’24 Nat. Rev. Gastroenterol. Hepatol. (IF 65.1) Pub Date : 2024-03-13 Katrina Ray
In February 2024, Nature Reviews Gastroenterology & Hepatology attended the 19th Congress of ECCO (ECCO’24) in Stockholm, Sweden. The meeting, according to the organizers, had >7,200 participants (represented by 99 countries) and focused on inflammatory bowel disease (IBD), with this year’s congress theme being ‘Crossing Borders in IBD’. The ‘crossing borders’ theme tied well with the new REACH strategy
-
Screening for liver fibrosis: lessons from colorectal and lung cancer screening Nat. Rev. Gastroenterol. Hepatol. (IF 65.1) Pub Date : 2024-03-13 Maja Thiele, Patrick S. Kamath, Isabel Graupera, Antoni Castells, Harry J. de Koning, Miquel Serra-Burriel, Frank Lammert, Pere Ginès
-
Gastrointestinal syndromes in Parkinson’s disease: risk factors or comorbidities? Gut (IF 24.5) Pub Date : 2024-03-13 Jiangwei Sun, Dan Yan, Karin Wirdefeldt, Jialu Yao, Jonas F Ludvigsson
With great interest, we read the article by Konings et al ,1 in which the authors conducted a combined case–control and cohort study and found that dysphagia, gastroparesis, irritable bowel syndrome (IBS) without diarrhoea and constipation specifically predict subsequent newly onset idiopathic Parkinson’s disease (PD) through comparing patients with PD with matched negative controls and patients with
-
Non-invasive assessment of MASH resolution Gut (IF 24.5) Pub Date : 2024-03-13 Jean-François Dufour, Vincent Wai-Sun Wong
With the approval of drug treatment for metabolic dysfunction-associated steatohepatitis (MASH) approaching, it is of paramount importance to have non-invasive means to monitor response to treatment.1 Currently, conditional approval is based on liver histology, with MASH resolution without worsening of fibrosis and fibrosis improvement without worsening of MASH being the two key histological endpoints
-
Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-14 Nina Dominik, Bernhard Scheiner, Alberto Zanetto, Lorenz Balcar, Georg Semmler, Elena Campello, Michael Schwarz, Rafael Paternostro, Benedikt Simbrunner, Benedikt S. Hofer, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Peter Quehenberger, Paolo Simioni, Thomas Reiberger, Mattias Mandorfer
-
Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial Gut Microbes (IF 12.2) Pub Date : 2024-03-13 Armin Rashidi, Maryam Ebadi, Tauseef Ur Rehman, Heba Elhusseini, David Kazadi, Hossam Halaweish, Mohammad H. Khan, Andrea Hoeschen, Qing Cao, Xianghua Luo, Amanda J. Kabage, Sharon Lopez, Shernan G. Holtan, Daniel J. Weisdorf, Chang Liu, Satoshi Ishii, Alexander Khoruts, Christopher Staley
In small series, third-party fecal microbiota transplantation (FMT) has been successful in decolonizing the gut from clinically relevant antibiotic resistance genes (ARGs). Less is known about the ...
-
Strengths and limitations of AlphaMissense in CPA1 missense variant classification Gut (IF 24.5) Pub Date : 2024-03-12 Ya-Hui Wang, Emmanuelle Masson, Zhuan Liao, Claude Férec, Wen-Bin Zou, Jian-Min Chen
We read with interest the publication by Sándor and Sahin-Tóth, which classifies CPA1 missense variants based on functional data.1 Previous analyses of variants strongly associated with chronic pancreatitis (p.N256K, p.S282P and p.K374E) have demonstrated that pathogenic CPA1 variants result in proenzyme misfolding, leading to subsequent endoplasmic reticulum (ER) stress.2–6 In examining 50 CPA1 missense
-
Inconsistencies in the predictive value of PD-L1 in metastatic gastroesophageal cancer Gastroenterol. Hepatol. (IF 35.7) Pub Date : 2024-03-13 Raghav Sundar, Elizabeth C Smyth
-
Esophageal Enigma: Isolated Lower Esophageal Sphincter Amyloidosis Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-13 Alam Merchant M.D, Raul S. Gonzalez M.D, Anand Jain M.D
-
Validation of the THCC-RI predictive model for hepatocellular carcinoma in Asian cohort Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-13 Jeong-Ju Yoo, Young-Gi Song, Ji Eun Moon, Young Seok Kim, Sang Gyune Kim
-
Risk of Cancer in Patients with Diverticular Disease: A Population-based Cohort Study Clin. Gastroenterol. Hepatol. (IF 12.6) Pub Date : 2024-03-13 Frederikke S. Troelsen, Dóra K. Farkas, Rune Erichsen, Lisa L. Strate, John A. Baron, Henrik T. Sørensen
Several studies have investigated the association between diverticular disease (DD) and colorectal cancer. However, whether there is an association between DD and malignancies other than those in the colorectum remains uncertain. For the 1978-2019 period, we conducted a nationwide, population-based cohort study using national Danish healthcare data. We followed DD patients for up to 20 years, beginning
-
Risk factors and treatment strategies for cholecystitis after metallic stent placement due to malignant biliary obstruction: a multicenter retrospective study Gastrointest. Endosc. (IF 7.7) Pub Date : 2024-03-13 Akihiro Matsumi M.D. Ph.D., Hironari Kato M.D. Ph.D., Taiji Ogawa M.D. Ph.D., Toru Ueki M.D. Ph.D., Masaki Wato M.D. Ph.D., Masakuni Fujii M.D. Ph.D., Tatsuya Toyokawa M.D. Ph.D., Ryo Harada M.D. Ph.D., Yuki Ishihara M.D. Ph.D., Masahiro Takatani M.D. Ph.D., Hirofumi Tsugeno M.D. Ph.D., Naoko Yunoki M.D. Ph.D., Takeshi Tomoda M.D. Ph.D., Toshiharu Mitsuhashi M.D. Ph.D., Motoyuki Otsuka M.D. Ph.D.
Cholecystitis can occur after self-expandable metallic stent (SEMS) placement for malignant biliary obstructions (MBO). Furthermore, the best treatment option for cholecystitis has not been determined. Here, we aimed to identify the risk factors of cholecystitis after SEMS placement and determine the best treatment option. Incidence, treatments, and predictive factors of cholecystitis were retrospectively
-
Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-13 Carolina Ramirez‐Cadiz, Hanna Blaney, Natalia Kubanek, Luis Antonio Díaz, Rohit Loomba, Lubomir Skladany, Juan Pablo Arab
-
Editorial: Shorter course of intravenous terlipressin in acute variceal bleeding—the promise, controversies and future directions. Author's reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-10 Sagnik Biswas, Manas Vaishnav, Shalimar
This article is linked to Vaishnav et al papers. To view these articles, visit https://doi.org/10.1111/apt.17868 and https://doi.org/10.1111/apt.17882
-
Group 3 innate lymphoid cells in intestinal health and disease Nat. Rev. Gastroenterol. Hepatol. (IF 65.1) Pub Date : 2024-03-11 Veronika Horn, Gregory F. Sonnenberg
-
Novel multimodal database for metabolic dysfunction-associated steatotic liver disease - linking genes to outcomes Gastroenterology (IF 29.4) Pub Date : 2024-03-12 Sara Naimimohasses, Mamatha Bhat
-
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-10 Amanda Ricciuto, Kuan Liu, Wael El-Matary, Mansi Amin, Achiya Z. Amir, Madeleine Aumar, Marcus Auth, Matthew D. Di Guglielmo, Eleonora Druve Tavares Fagundes, Alexandre Rodrigues Ferreira, Katryn N. Furuya, Nitika Gupta, Stephen Guthery, Simon P. Horslen, Kyle Jensen, Binita M. Kamath, Nanda Kerkar, B. G. P. Koot, Trevor J. Laborda, Christine K. Lee, Kathleen M. Loomes, Cara Mack, Mercedes Martinez
-
Applying Lyon consensus criteria in the work-up of patients with extra-oesophageal symptoms – A multicentre retrospective study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-06 Francesco Calabrese, Andrea Pasta, Giorgia Bodini, Manuele Furnari, Patrizia Zentilin, Edoardo G. Giannini, Daria Maniero, Domenico Della Casa, Giovanni Cataudella, Marzio Frazzoni, Roberto Penagini, Arsiè Elena, Nicola de Bortoli, Pierfrancesco Visaggi, Vincenzo Savarino, Edoardo Savarino, Elisa Marabotto
-
Development and validation of a brain fog scale for coeliac disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-06 Simon R. Knowles, Pragalathan Apputhurai, Jason A. Tye-Din
-
ZntA maintains zinc and cadmium homeostasis and promotes oxidative stress resistance and virulence in Vibrio parahaemolyticus Gut Microbes (IF 12.2) Pub Date : 2024-03-11 Chengkun Zheng, Yimeng Zhai, Jun Qiu, Mengxian Wang, Zhengzhong Xu, Xiang Chen, Xiaohui Zhou, Xinan Jiao
Although metals are essential for life, they are toxic to bacteria in excessive amounts. Therefore, the maintenance of metal homeostasis is critical for bacterial physiology and pathogenesis. Vibri...
-
Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of Immunotherapy Gastroenterology (IF 29.4) Pub Date : 2024-03-11 Daowei Yang, Xinlei Sun, Rohan Moniruzzaman, Hua Wang, Citu Citu, Zhongming Zhao, Ignacio I. Wistuba, Huamin Wang, Anirban Maitra, Yang Chen
Pancreatic ductal adenocarcinoma (PDAC) has a desmoplastic tumor stroma and immunosuppressive microenvironment. Galectin-3 (GAL3) is enriched in PDAC, highly expressed by cancer cells and myeloid cells. However, the functional roles of GAL3 in the PDAC microenvironment remain elusive. We generated a novel transgenic mouse model (KPPC;Lgals3) that allows the genetic depletion of GAL3 from both cancer
-
Biopsy proteome scoring to determine mucosal remodeling in celiac disease Gastroenterology (IF 29.4) Pub Date : 2024-03-11 Anette Johansen, Geir Kjetil F. Sandve, Jostein Holen Ibsen, Knut E.A. Lundin, Ludvig M. Sollid, Jorunn Stamnaes
Histological evaluation of gut biopsies is a cornerstone for diagnosis and management of celiac disease (CeD). Despite its wide use, the method depends on proper biopsy orientation, and it suffers from inter-observer variability. Biopsy proteome measurement reporting on tissue state can be obtained by mass spectrometry (MS) analysis of formalin-fixed paraffin embedded (FFPE) tissue. Here we aimed to
-
THORACOABDOMINAL WALL MOTION-GUIDED BIOFEEDBACK TREATMENT OF ABDOMINAL DISTENSION: A RANDOMIZED PLACEBO-CONTROLLED TRIAL Gastroenterology (IF 29.4) Pub Date : 2024-03-11 Elizabeth Barba M.D., Dan M. Livovsky M.D., Anna Accarino M.D., Fernando Azpiroz M.D.
Abdominal distention results from abdominophrenic dyssynergia (diaphragmatic contraction and abdominal wall relaxation) in patients with disorders of the gut-brain interaction. This study aimed to validate a simple biofeedback procedure, guided by abdominothoracic wall motion, for treating abdominal distension. In this randomized, parallel, placebo-controlled trial, 42 consecutive patients (36 women
-
Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction‐associated steatotic liver disease—authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Nipun Verma, Arka De, Ajay Duseja
LINKED CONTENTThis article is linked to Verma et al papers. To view these articles, visit https://doi.org/10.1111/apt.17891 and https://doi.org/10.1111/apt.17902
-
Editorial: Gastrointestinal symptoms—A world of differences Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Kevin W. Olden
LINKED CONTENTThis article is linked to Palsson et al paper. To view this article, visit https://doi.org/10.1111/apt.17894
-
Letter: Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B can increase body weight Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Youwen Tan, Sainan Zheng
LINKED CONTENTThis article is linked to Ogawa et al papers. To view these articles, visit https://doi.org/10.1111/apt.17107 and https://doi.org/10.1111/apt.17910
-
Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Haibo Jing, Lin Lin, Juan Xu, Huifeng Zhang, Lin Cao, Yaofu Fan
LINKED CONTENTThis article is linked to Martini et al papers. To view these articles, visit https://doi.org/10.1111/apt.17804 and https://doi.org/10.1111/apt.17916
-
Editorial: Shorter course of intravenous terlipressin in acute variceal bleeding ‐ the promise, controversies and future directions Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Yu Jun Wong, Juan G. Abraldes
LINKED CONTENTThis article is linked to Vaishnav et al papers. To view these articles, visit https://doi.org/10.1111/apt.17868 and https://doi.org/10.1111/apt.17893
-
Letter: Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B can increase body weight—Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Eiichi Ogawa
LINKED CONTENTThis article is linked to Ogawa et al papers. To view these articles, visit https://doi.org/10.1111/apt.17107 and https://doi.org/10.1111/apt.17896
-
Editorial: Corticosteroids for severe checkpoint inhibitor‐induced liver injury—Not one size fits all? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Morven Cunningham
LINKED CONTENTThis article is linked to Riveiro‐Barciela et al paper. To view this article, visit https://doi.org/10.1111/apt.17898
-
Editorial: The tsunami of steatotic liver disease in India, the Asia‐Pacific region and the world—Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-11 Manya Prasad, Tushar Prabhakar, Shiv Kumar Sarin
LINKED CONTENTThis article is linked to Prabhakar et al papers. To view these articles, visit https://doi.org/10.1111/apt.17892 and https://doi.org/10.1111/apt.17903